Study on fasting for diabetes & metabolic syndrome
Chenying Li et al.
April 2017
Diet, Fasting & Detox
Diabetes
High blood pressure
The pilot study investigated the effects of a one-week fasting period compared to standard treatment in type 2 diabetes. Patients with T2D were assigned to either a 7-day fasting program or standard treatment.
Fasting resulted in significant weight loss, a reduction in blood pressure and improved quality of life. However, there were no significant improvements in HbA1c, insulin and HOMA index.
The study suggests that long-term fasting is safe and has potentially positive clinical effects. However, further research is needed to confirm the efficacy of fasting and to investigate long-term effects.
The most important information on the study at a glance
- Indications
- Diabetes, metabolic syndrome, high blood pressure, obesity
- Institution
- Institute of Social Medicine, Epidemiology and Health Economics, Charité University Medical Center, Berlin, Germany
- Title
- Study on the effectiveness of one-week fasting for type 2 diabetes and metabolic syndrome
- Brief description
- The study shows that one week of fasting in type 2 diabetes significantly improves weight, blood pressure and quality of life.
- Original title
- Effects of A One-week Fasting Therapy in Patients with Type-2 Diabetes Mellitus and Metabolic Syndrome - A Randomized Controlled Explorative Study
- Link to the study
- https://pubmed.ncbi.nlm.nih.gov/28407662/
Suitable trips for this study topic
You might also be interested in
Intermittent fasting
Overweight / obesity
Hassane Zouhal et al.
August 2020
This study shows that intermittent fasting has a positive effect on appetite-regulating hormones in overweight men.
Other fasting
Overweight / obesity
N. M. Hussin et al.
January 2013
The study shows that fasting and calorie restriction can effectively improve mood and nutritional status in older men.
High blood pressure
Other fasting
András Maifeld et al.
March 2021
The study shows that fasting followed by a DASH diet significantly lowers blood pressure and BMI in patients with metabolic syndrome.